Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4LJO1
|
|||
| Drug Name |
RGN-137
|
|||
| Synonyms |
Thymosin Beta 4 (topical gel)
Click to Show/Hide
|
|||
| Drug Type |
Peptide
|
|||
| Indication | Epidermolysis bullosa [ICD-11: EC3Z] | Phase 2 | [1] | |
| Company |
RegeneRx Biopharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03578029) Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (CELEB). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.